Drug Index

Mechanism :

Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine produces positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on beta-adrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings.

Indication :

  • Hypotension
  • Shock
  • Septicemia

Contraindications :

Dopamine should not be used in patients with pheochromocytoma, in patients with uncorrected tachyarrhythmias or ventricular fibrillation.

Dosing :

1-5 microgram/kg/min IV which can be increased to 5-20 microgram/kg/min. (Max dose: 50 mcg/kg/min). 5-15 mcg/kg/min has a cardiogenic effect. 15-20 mcg/kg/min has a vasoconstrictor effect.

Adverse Effect :

Tachycardia, ectopic beats, anginal pain, vasoconstriction, palpitation, nausea, hypotension, vomiting, headache, dyspnea, aberrant conduction, bradycardia, widened QRS complex, hypertension and gangrene.

Interaction :

MAO inhibitors: Inhibition of this enzyme prolongs and potentiates the effect of dopamine.
Diuretic agents: May produce an additive or potentiating effect on urine flow.
Tricyclic Antidepressants: May potentiate the cardiovascular effects of adrenergic agents
Beta-adrenergic Blocking Agents: Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents.
Cyclopropane or Halogenated Hydrocarbon Anesthetics: Increase cardiac autonomic irritability and may sensitize the myocardium to the action of dopamine and may produce ventricular arrhythmias and hypertension.
Vasopressors, Vasoconstricting Agents: May result in severe hypertension.
Phenytoin: Lead to hypotension and bradycardia.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function
HDNot dialysed. Dose as in normal renal function
HDF/High fluxNot dialysed. Dose as in normal renal function
CAV/VVHDNot dialysed. Dose as in normal renal function

Hepatic Dose :

No dosage adjustments are recommended. Titrate the dopamine infusion rate as per clinical response.
09/28/2020 07:56:43 Dopamine
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0